Clinical Study

A Phase Ib, Open-Label, Dose Escalation Trial Investigating Different Doses And Schedules Of Sym004 In Combination With Platinum-Doublets In Subjects

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Specialties:
  • Type of Study: Drug

The purpose of a Phase I study is to find the best way to give an investigational drug (for example, by mouth, intravenous infusion, or injection) and/or the best dose. In Phase I studies, the dose is usually increased a little at a time until several participants have serious side effects.

Criteria:

To Qualify For This Study You Must Have Been Diagnosed With Stage Iv Nsclc.

Keywords:

Cancer, Lung, Emr200637-003, Nsclc, Stage Iv

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.